Compare CVX & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVX | ABT |
|---|---|---|
| Founded | 1879 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.7B | 152.9B |
| IPO Year | 1994 | 2006 |
| Metric | CVX | ABT |
|---|---|---|
| Price | $170.29 | $94.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 20 |
| Target Price | ★ $191.80 | $130.90 |
| AVG Volume (30 Days) | 6.1M | ★ 9.6M |
| Earning Date | 05-01-2026 | 04-16-2026 |
| Dividend Yield | ★ 3.70% | 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.11 | 0.61 |
| Revenue | ★ $189,031,000,000.00 | $44,328,000,000.00 |
| Revenue This Year | $18.01 | $10.75 |
| Revenue Next Year | N/A | $8.10 |
| P/E Ratio | $155.15 | ★ $152.64 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $142.40 | $81.97 |
| 52 Week High | $214.71 | $137.49 |
| Indicator | CVX | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 31.92 | 63.35 |
| Support Level | $147.71 | $86.02 |
| Resistance Level | $193.41 | $112.81 |
| Average True Range (ATR) | 3.36 | 2.21 |
| MACD | -1.35 | 0.64 |
| Stochastic Oscillator | 3.59 | 86.49 |
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.0 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.7 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2024 stood at 9.8 billion barrels of oil equivalent, including 5.1 billion barrels of liquids and 28.4 trillion cubic feet of natural gas.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.